Multisite Oral Amoxicillin Challenges During Pediatric Emergency Department Visits

David Vyles; George Hoganson; Constance McAneney; Mariana Castells; Elizabeth J Phillips; Alexis Visotcky; David C Brousseau

doi:10.1001/jamapediatrics.2023.3659

Multisite Oral Amoxicillin Challenges During Pediatric Emergency Department Visits

JAMA Pediatr. 2023 Dec 1;177(12):1348-1350. doi: 10.1001/jamapediatrics.2023.3659.

Authors

David Vyles¹, George Hoganson², Constance McAneney³, Mariana Castells⁴, Elizabeth J Phillips⁵, Alexis Visotcky¹, David C Brousseau¹

Affiliations

¹ Medical College of Wisconsin, Milwaukee.
² Washington University School of Medicine, St Louis, Missouri.
³ Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
⁴ Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
⁵ Vanderbilt University School of Medicine, Nashville, Tennessee.

PMID: 37782486
PMCID: PMC10546289 (available on 2024-10-02)
DOI: 10.1001/jamapediatrics.2023.3659

No abstract available

Plain language summary

This cohort study assesses differences in children’s allergy risk level designation and results of a direct oral challenge via a penicillin allergy delabeling process.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Amoxicillin*
Anti-Bacterial Agents
Child
Emergency Service, Hospital
Humans
Penicillins*

Substances

Amoxicillin
Penicillins
Anti-Bacterial Agents